Jiebin Dong

688 total citations
6 papers, 135 citations indexed

About

Jiebin Dong is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Jiebin Dong has authored 6 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 2 papers in Biomedical Engineering. Recurrent topics in Jiebin Dong's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (1 paper). Jiebin Dong is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (1 paper). Jiebin Dong collaborates with scholars based in China and United States. Jiebin Dong's co-authors include Hongkui Deng, Yun Bai, Changwen Deng, Jingjing Zhao, Shixin Zhou, Jun Xu, Zhen Liang, Zhen Liu, Jijia Pan and Shicheng Wei and has published in prestigious journals such as ACS Applied Materials & Interfaces, Cell stem cell and Molecular Therapy.

In The Last Decade

Jiebin Dong

6 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiebin Dong China	5	85	56	49	42	25	6	135
Agata Rybicka Poland	8	73 0.9×	79 1.4×	31 0.6×	94 2.2×	20 0.8×	10	326
Somayeh Shamlou Iran	4	76 0.9×	24 0.4×	35 0.7×	81 1.9×	36 1.4×	6	154
Megan M. Dacek United States	8	147 1.7×	63 1.1×	69 1.4×	66 1.6×	43 1.7×	12	200
Giulia Cattaneo United States	5	133 1.6×	50 0.9×	72 1.5×	40 1.0×	34 1.4×	15	178
Elise Gray-Gaillard United States	5	93 1.1×	44 0.8×	52 1.1×	102 2.4×	36 1.4×	7	228
Qumiao Xu China	8	123 1.4×	23 0.4×	76 1.6×	109 2.6×	30 1.2×	16	219
Ting Yue China	8	37 0.4×	33 0.6×	60 1.2×	64 1.5×	9 0.4×	19	168
Christopher M. Bourne United States	10	150 1.8×	59 1.1×	92 1.9×	121 2.9×	44 1.8×	17	263
Juliana Dias United Kingdom	5	158 1.9×	69 1.2×	41 0.8×	74 1.8×	43 1.7×	6	182
Jiangqing Chen China	7	218 2.6×	64 1.1×	108 2.2×	96 2.3×	57 2.3×	9	282

Countries citing papers authored by Jiebin Dong

Since Specialization

Citations

This map shows the geographic impact of Jiebin Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiebin Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiebin Dong more than expected).

Fields of papers citing papers by Jiebin Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiebin Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiebin Dong. The network helps show where Jiebin Dong may publish in the future.

Co-authorship network of co-authors of Jiebin Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Jiebin Dong. A scholar is included among the top collaborators of Jiebin Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiebin Dong. Jiebin Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zhu, Jialiang, Jun Cao, Zhengyang Zhou, et al.. (2024). Generation of human expandable limb-bud-like progenitors via chemically induced dedifferentiation. Cell stem cell. 31(12). 1732–1740.e6. 4 indexed citations

2.

Zhao, Jingjing, Jiebin Dong, Changwen Deng, et al.. (2023). Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor. OncoImmunology. 12(1). 2265703–2265703. 4 indexed citations

3.

Lai, Weifeng, Yuting Liu, Feng Zheng, et al.. (2021). Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors. Stem Cell Reports. 16(7). 1697–1704. 22 indexed citations

4.

Luo, Zuyuan, Zhen Liu, Zhen Liang, et al.. (2020). Injectable Porous Microchips with Oxygen Reservoirs and an Immune-Niche Enhance the Efficacy of CAR T Cell Therapy in Solid Tumors. ACS Applied Materials & Interfaces. 12(51). 56712–56722. 33 indexed citations

5.

Deng, Changwen, Jingjing Zhao, Shixin Zhou, et al.. (2019). The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors. Molecular Therapy. 28(1). 75–88. 57 indexed citations

6.

Sun, Qiang, Shixin Zhou, Jingjing Zhao, et al.. (2018). Engineered T lymphocytes eliminate lung metastases in models of pancreatic cancer. Oncotarget. 9(17). 13694–13705. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact